Overall Survival of Patients With ALK-Positive Metastatic Non–Small-Cell Lung Cancer in the Russian Federation: Nationwide Cohort Study

PURPOSE: The overall survival (OS) results in patients with ALK-positive metastatic non–small-cell lung cancer (NSCLC) have rarely been reported. The aim of this prospective-retrospective cohort study was to obtain real-world data on the use of crizotinib or chemotherapy in patients with ALK-positiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsimafeyeu, Ilya, Moiseenko, Fedor, Orlov, Sergei, Filippova, Elena, Belonogov, Alexander, Nebesnykh, Aleksey, Khalimov, Amir, Karabina, Elena, Shikina, Valentina, Abdelgafur, Ahmed, Statsenko, Galina, Titova, Irina, Isaichikov, Dmitry, Makarnyaeva, Galina, Mordovskiy, Aleksey, Barkovskaya, Oksana, Smirnov, Aleksey, Gikalo, Marina, Savelov, Nikita, Kosov, Dmitry, Imyanitov, Evgeny, Demidova, Irina, Tjulandin, Sergei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Clinical Oncology 2019
Materias:
ORIGINAL REPORT
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6550093/
https://www.ncbi.nlm.nih.gov/pubmed/31095455
http://dx.doi.org/10.1200/JGO.19.00024

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6550093/
https://www.ncbi.nlm.nih.gov/pubmed/31095455
http://dx.doi.org/10.1200/JGO.19.00024

Ejemplares similares